Here's What Trump Did After That Pharma Executive Collapsed in the Oval Office
Supreme Court Issues Emergency Order Temporarily Blocking Full SNAP Payments
A Century Later, Some Haven't Learned History's Lessons on Communism
Video From Condé Nast Shows It Is Like a Daycare Center for Journos...
Maine Voters OK Red Flag Law Because Experts Blew It
100-Year-Old WWII Veteran Says the Sacrifices of His Generation Were Not Worth It
The Evil Unleashed in 2008: From Obama, to Biden, to Harris, to Mamdani
Surrender, But Don't Give Yourself Away
A Veterans Day Call to Restore the Warrior Corps
Bringing Back Hemp Prohibition Would Be a Massive Mistake
Congress Shouldn’t Bury a Hemp Ban in a Bill to Feed Families and...
Federal Judge Blocks Trump From Sending Troops to Portland
Trump Orders DOJ to Investigate Foreign Meat-Packing Companies Over Price-Fixing
US Strikes Deal to Restore Funding to Cornell University
38 Charged Following Investigations by the Nashville Homeland Security Task Force
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement